We are live on ! Find out more
ACHL

Achilles Therapeutics
ACHL

Delisted

ACHL was delisted on the 20th of March, 2025.

Back to rankings

2 hedge funds and large institutions have $7.82K invested in Achilles Therapeutics in 2025 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

0% more capital invested

Capital invested by funds: $7.82K → $7.82K ($0)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
1
RhumbLine Advisers
Massachusetts
$6.63K – – –
GI
2
GAMMA Investing
California
$1.19K – – –

ACHL Hedge Fund Activity: Q3 2025 in Review

2 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Achilles Therapeutics (ACHL) for Q3 2025, worth a combined $7.82K — unchanged from a quarter earlier.

Fund positioning in ACHL was balanced in Q3 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held Achilles Therapeutics (ACHL) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $7.82K of Achilles Therapeutics stock for Q3 2025, unchanged quarter-over-quarter.
  • 0 funds opened new Achilles Therapeutics positions in Q3 2025 and 0 closed out.

Based on aggregated 13F filings for Q3 2025.